Canada markets closed

Shin Nippon Biomedical Laboratories, Ltd. (YB3.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
8.15+0.20 (+2.52%)
At close: 08:10AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
26,450,468
25,090,903
17,748,482
15,110,548
Cost of Revenue
12,167,891
12,044,235
8,061,183
7,556,144
Gross Profit
14,282,576
13,046,668
9,687,299
7,554,403
Operating Expenses
Research Development
1,741,195
683,065
425,075
392,238
Selling General and Administrative
1,931,321
1,348,220
1,000,617
835,079
Total Operating Expenses
10,120,211
7,801,426
5,491,682
5,024,862
Operating Income or Loss
4,162,365
5,245,242
4,195,617
2,529,541
Interest Expense
138,783
125,060
126,646
184,860
Income Before Tax
6,974,444
7,759,612
8,183,311
4,175,563
Income Tax Expense
1,456,736
1,708,903
1,016,205
497,792
Income from Continuing Operations
5,517,708
6,050,709
7,167,106
3,677,771
Net Income
5,531,261
6,060,057
7,127,629
3,661,855
Net Income available to common shareholders
5,531,261
6,060,057
7,127,629
3,661,855
Basic EPS
110.64
145.56
171.20
87.95
Diluted EPS
110.64
145.56
171.20
87.95
Basic Average Shares
41,631
41,631
41,632
41,632
Diluted Average Shares
41,632
41,631
41,632
41,632